Pharma Focus Europe's current edition focuses on biotech partnerships and the challenges faced by US generics, alongside advancements in digital labs and AI in drug discovery. It explores developments in gene therapy, respiratory treatments, Mass Spectrometry, genomic medicine, AI in recruitment, and data-driven R&D, offering insights into European pharmaceutical innovation.
We are thrilled to present the muchanticipated third edition of Pharma Focus Europe magazine for
Biotechnology an industry at the forefront of scientific innovation and transformative healthcare solutions
In recent years the United States has witnessed a remarkable phenomenon in the pharmaceutical industry
Recent industry pressures brought on by the global COVID pandemic provided critical lessons for the life sciences industry
Quantitative systems pharmacology QSP combines computational modeling and experimental data to examine the relationships between a drug
Today there are more than known rare diseases defined by the European Union as conditions that affect less than in people
Advancements in medical science have continually pushed the boundaries of what is possible in healthcare
After a lead protein design is selected for clinical trials biologics manufacturing also known as chemistry manufacturing and control
Continuous manufacturing methods have been extensively demonstrated to have a significant impact on improving quality
The sterile pharmaceutical market is expected to expand significantly in the coming years due to the increasing demand for biological drugs
Genomic medicine the therapeutic use of cells and genetic materials is at the center of a medical revolution
With more clinical trials getting decentralized and the adoption of AIML witnessing an upward trend
Datadriven decisionmaking is becoming mainstream in various stages of drug development and is transforming the drug development lifecycle
